Cargando…
Comments on “Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer” [Letter]
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995159/ https://www.ncbi.nlm.nih.gov/pubmed/35418753 http://dx.doi.org/10.2147/IJN.S357154 |
| _version_ | 1784684254069784576 |
|---|---|
| author | Wang, Xin |
| author_facet | Wang, Xin |
| author_sort | Wang, Xin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8995159 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89951592022-04-12 Comments on “Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer” [Letter] Wang, Xin Int J Nanomedicine Letter Dove 2022-04-06 /pmc/articles/PMC8995159/ /pubmed/35418753 http://dx.doi.org/10.2147/IJN.S357154 Text en © 2022 Wang. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Letter Wang, Xin Comments on “Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer” [Letter] |
| title | Comments on “Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer” [Letter] |
| title_full | Comments on “Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer” [Letter] |
| title_fullStr | Comments on “Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer” [Letter] |
| title_full_unstemmed | Comments on “Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer” [Letter] |
| title_short | Comments on “Emodin-Conjugated PEGylation of Fe(3)O(4) Nanoparticles for FI/MRI Dual-Modal Imaging and Therapy in Pancreatic Cancer” [Letter] |
| title_sort | comments on “emodin-conjugated pegylation of fe(3)o(4) nanoparticles for fi/mri dual-modal imaging and therapy in pancreatic cancer” [letter] |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995159/ https://www.ncbi.nlm.nih.gov/pubmed/35418753 http://dx.doi.org/10.2147/IJN.S357154 |
| work_keys_str_mv | AT wangxin commentsonemodinconjugatedpegylationoffe3o4nanoparticlesforfimridualmodalimagingandtherapyinpancreaticcancerletter |